Match tier Institution-verified
Presence Current · Arkansas
Last published 2026
Sources Institutional record
Refreshed 2026-10-05

Rutu Aniruddha Rathod

Sourced from institutional research profiles (UAMS TRI or ARA).

Assistant Professor

CPH | Epidemiology

3 h-index 22 pubs 20 cited

  • Immune Checkpoint Inhibitors
  • Neoplasms
  • Metabolic Syndrome
  • Drug-Related Side Effects and Adverse Reactions
  • Aged
  • Female
  • Humans
  • Male
  • Middle Aged
  • Prospective Studies
  • Risk Factors
  • Cytokines

Edit your profile

Biography and Research Information

OverviewAI-generated summary

Rutu Aniruddha Rathod's research focuses on the intersection of metabolic health and the efficacy and safety of cancer treatments. Rathod's work specifically investigates the relationship between metabolic syndrome and immune-related adverse events (irAEs) associated with immune checkpoint inhibitors. This area of study is critical for understanding how pre-existing metabolic conditions may influence patient responses to advanced cancer therapies.

Published in 2026, Rathod's work includes a study on metabolic syndrome and immune-related adverse events, with a subsequent correction also published in the same year. These publications indicate recent activity and engagement with this specific research question. Rathod's current scholarly metrics show a total of one publication.

Metrics

  • h-index: 3
  • Publications: 22
  • Citations: 20

Selected Publications

  • Neighborhood Economic Deprivation, Hispanic Ethnic Enclaves, and Congenital Anomalies in Texas (2026)
    Birth Defects Research DOI OpenAlex
  • Neighborhood Factors and Treatment Outcomes in Pediatric Acute Lymphoblastic Leukemia: A REDIAL Consortium Report (2026)
    Cancer Research Communications DOI OpenAlex
  • Correction: Metabolic syndrome and immune-related adverse events (2026)
    Cancer Immunology Immunotherapy DOI OpenAlex
  • Abstract 870: Neighborhood disparities and treatment outcomes in pediatric acute lymphoblastic leukemia (ALL): A report from the REDIAL Consortium. (2026)
    Cancer Research DOI OpenAlex
  • Metabolic syndrome and immune-related adverse events (2026)
    Cancer Immunology Immunotherapy 2 citations DOI OpenAlex
  • Abstract 7408: Factors influencing false positive low-dose computed tomography-based lung cancer screening in an urban, safety-net system (2025)
    Cancer Research 1 citation DOI OpenAlex
  • Neighborhood Factors Related to Cancer Screening in Texas: A Spatioecological Study (2024)
    American Journal of Preventive Medicine 5 citations DOI OpenAlex

Grants & Funding

As listed on this researcher's institutional profile.

  • GLP-1 Based Therapies on Lymphedema in Overweight or Obese Breast Cancer Patients State of Arkansas via Arkansas Breast Cancer Research Program Principal Investigator

Collaboration Network

17 Collaborators 3 Institutions 1 Country

Top Collaborators

Similar Researchers

Based on overlapping research topics